Leerink Partners analyst Whit Mayo raised the price target on Enhabit Home Health & Hospice (NYSE: EHAB) to $13.80 (from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE